This protein may be a clinically important predictor of recurrence of breast cancer (Kuhajda et al., 1989), Epelbaum R et al. found that HPR is a new tumor marker, which has potential use in the clinical setting of lymphoma (Epelbaum et al., 1998). This evidence concerns the gene HPR and neoplasm.